Siponimod-d 11

Overview

Siponimod -d 11 (BAF-312-d 11 ) is deuterium labeled Siponimod ( HY-12355 ). Siponimod is an orally active, blood-brain barrier penetrant dual agonist of S1P1 / S1P5 , with EC 50 values of 0.39 nM and 0.98 nM, respectively. Siponimod induces S1P1 internalization, activates GIRK channels, inhibits lymphocyte egress, reduces peripheral lymphocyte counts, triggers transient bradycardia, prevents synaptic neurodegeneration, promotes remyelination, alleviates demyelination, and prevents the loss of GABAergic interneurons. Siponimod can be used in research related to multiple sclerosis.

Application

Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Inflammation or Immune System Disease | Products > Signaling Pathways > Others | Products > Signaling Pathways > Membrane Transporter/Ion Channel | Products > Signaling Pathways > GPCR/G Protein | Products > Research Areas > Neurological Disease | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > Isotope-Labeled Compounds | Products > Signaling Pathways > Potassium Channel | Products > Signaling Pathways > LPL Receptor

Product Information

• Catalog No.: HY-12355S
• CAS No.: 2104759-32-0
• Molecular Formula: C29H24D11F3N2O3
• Molecular Weight: 527.66
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.
• Availability: In-stock

Source

Original product source